Denmark · Delayed Price · Currency is DKK Embla Medical Statistics
Total Valuation
Embla Medical has a market cap or net worth of DKK 14.45 billion. The enterprise value is 17.40 billion.
| Market Cap | 14.45B |
| Enterprise Value | 17.40B |
Important Dates
The next estimated earnings date is Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Embla Medical has 427.65 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 427.65M |
| Shares Outstanding | 427.65M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | +3.07% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 73.40% |
| Float | 162.13M |
Valuation Ratios
The trailing PE ratio is 29.51 and the forward PE ratio is 22.69. Embla Medical's PEG ratio is 1.26.
| PE Ratio | 29.51 |
| Forward PE | 22.69 |
| PS Ratio | 2.53 |
| PB Ratio | 2.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.25 |
| P/OCF Ratio | 18.29 |
| PEG Ratio | 1.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.12, with an EV/FCF ratio of 24.37.
| EV / Earnings | 35.44 |
| EV / Sales | 3.05 |
| EV / EBITDA | 15.12 |
| EV / EBIT | 20.71 |
| EV / FCF | 24.37 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.84 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | 5.01 |
| Interest Coverage | 6.03 |
Financial Efficiency
Return on equity (ROE) is 9.36% and return on invested capital (ROIC) is 5.68%.
| Return on Equity (ROE) | 9.36% |
| Return on Assets (ROA) | 4.74% |
| Return on Invested Capital (ROIC) | 5.68% |
| Return on Capital Employed (ROCE) | 8.54% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | 122,755 |
| Employee Count | 4,061 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, Embla Medical has paid 156.96 million in taxes.
| Income Tax | 156.96M |
| Effective Tax Rate | 24.13% |
Stock Price Statistics
The stock price has decreased by -5.59% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -5.59% |
| 50-Day Moving Average | 31.78 |
| 200-Day Moving Average | 31.66 |
| Relative Strength Index (RSI) | 62.53 |
| Average Volume (20 Days) | 54,562 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Embla Medical had revenue of DKK 5.71 billion and earned 491.02 million in profits. Earnings per share was 1.15.
| Revenue | 5.71B |
| Gross Profit | 3.58B |
| Operating Income | 798.14M |
| Pretax Income | 650.55M |
| Net Income | 491.02M |
| EBITDA | 925.74M |
| EBIT | 798.14M |
| Earnings Per Share (EPS) | 1.15 |
Balance Sheet
The company has 649.75 million in cash and 3.58 billion in debt, giving a net cash position of -2.93 billion or -6.85 per share.
| Cash & Cash Equivalents | 649.75M |
| Total Debt | 3.58B |
| Net Cash | -2.93B |
| Net Cash Per Share | -6.85 |
| Equity (Book Value) | 5.54B |
| Book Value Per Share | 12.91 |
| Working Capital | 1.35B |
Cash Flow
In the last 12 months, operating cash flow was 790.47 million and capital expenditures -76.55 million, giving a free cash flow of 713.92 million.
| Operating Cash Flow | 790.47M |
| Capital Expenditures | -76.55M |
| Free Cash Flow | 713.92M |
| FCF Per Share | 1.67 |
Margins
Gross margin is 62.74%, with operating and profit margins of 13.98% and 8.60%.
| Gross Margin | 62.74% |
| Operating Margin | 13.98% |
| Pretax Margin | 11.40% |
| Profit Margin | 8.60% |
| EBITDA Margin | 16.22% |
| EBIT Margin | 13.98% |
| FCF Margin | 12.51% |
Dividends & Yields
Embla Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | 3.40% |
| FCF Yield | 4.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Embla Medical has an Altman Z-Score of 3.02 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.02 |
| Piotroski F-Score | 6 |